A new drug, toceranib phosphate (Palladia--Pfizer), has been approved for treating this common form of skin cancer in dogs.
A new drug, toceranib phosphate (Palladia--Pfizer), has been approved for treating this common form of skin cancer in dogs. Click here to read more.
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.